Evotec Aktiengesellschaft - Product Pipeline Review - 2012


Naperville, IL -- (SBWIRE) -- 06/06/2012 -- Evotec Aktiengesellschaft Product Pipeline Review 2012 provides data on the Evotec Aktiengesellschaft’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Evotec Aktiengesellschaft’s corporate website, SEC filings, investor presentations and featured press releases, both from Evotec Aktiengesellschaft and industry-specific third party sources, put together by Global Markets Direct’s team.


- Evotec Aktiengesellschaft - Brief Evotec Aktiengesellschaft overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Evotec Aktiengesellschaft human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Evotec Aktiengesellschaft with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Evotec Aktiengesellschaft’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Evotec Aktiengesellschaft’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Evotec Aktiengesellschaft in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Evotec Aktiengesellschaft’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Evotec Aktiengesellschaft.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Evotec Aktiengesellschaft and identify potential opportunities in those areas.


Current R&D Portfolio of Evotec Aktiengesellschaft; Evotec Aktiengesellschaft - Key Therapeutics; Evotec Aktiengesellschaft - Pipeline Overview and Promising Molecules; Evotec Aktiengesellschaft - News; Evotec Aktiengesellschaft - Latest Updates; Evotec Aktiengesellschaft - Pipeline; Evotec Aktiengesellschaft - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: